Navigation Links

AxioMed Energized by Publication Showing Success of Outpatient Cervical Disc Replacements

Malden, MA (PRWEB) February 24, 2017 A study recently published in Spine shows total disc replacement (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical and patient-reported outcomes, when compared to anterior cervical discectomy and fusi... [Comments]

Delpor Awarded NIH Grant for 3-month Olanzapine Implant for the Treatment of Schizophrenia

SAN FRANCISCO, CA (PRWEB) February 24, 2017 Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced the awarding of a $224K grant from the National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-... [Comments]

Lajollacooks4u Explores Food and Wine Scene Around South Africa

San Diego, Calif. (PRWEB) February 24, 2017 Chef Jodi Abel has returned from her three-week tour through the South African food and wine scene. Making stops in several cities, she gained a number of delicious recipes and new techniques to share with her Lajollacooks4u guests. Her culinar... [Comments]

Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline

KNOXVILLE, Tenn. , Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, today is providing additional information regarding the deadline to participate in its previously announced rights offering of up to 19 million units, consisting of shares... [Comments]

Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

SAN DIEGO , Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: AEMD ), today released the following note authored by its Chairman and CEO, Jim Joyce . In a chilling address at the Munich Security Conference last Saturday, Bill Gates warned world leaders that a genetically engineered virus could kill more people than nuclear weapons. Mr. Gates expressed his concern, which... [Comments]

Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease

SAN FRANCISCO , Feb. 24, 2017 Symic Bio, a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics, announced today the completion of enrollment for the SHIELD clinical trial of SB-030 in peripheral artery disease. The trial will evaluate the safety and efficacy of SB-030, a locally administered single-use therapeutic, in the reduc... [Comments]

Natural Trends, Anti-pollution Protection Claims, and New Technologies are the Cornerstones of the Specialty Actives Market's Strong Growth, Finds Kline

PARSIPPANY, N.J. , Feb. 24, 2017  Driven by consumers' preference towards more natural products, botanicals and biotechnology are now the fastest growing categories, finds the recently published U.S. volume from the Specialty Actives in Personal Care: Multi-regional Market Analysis and Opportunities study by global market research and management consulting firm Kline.... [Comments]

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017

HONG KONG, Feb. 24, 2017 China Cord Blood Corporation (NYSE: CO ) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal year 2017 ended December 31, 2016. Third... [Comments]

FireflySci USA Expands Spectrophotometer Calibration Standard Network to Canada

Staten Island, NY (PRWEB) February 24, 2017 FireflySci, Inc is an explosive small business that continues to grow at an exponential rate. Founded in late 2014, FireflySci had the goal of bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy world. Now in 20... [Comments]

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016

BEIJING, Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2016. Fourth Quarter 2016 Financial Highlights Total sales in the fourth quarter of 2016 increased by 21.7% in RMB... [Comments]

(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
Breaking Biology News(10 mins):
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... index chromatography system, uses the highly sensitive ... processing is provided by the CE 4900 interface ... pressure CE 4100 dual piston pump. A ... The system can be upgraded to provide binary ...
capacity 250 mL...
Rabbit polyclonal to YANK2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide selected within aa 300~400 (C terminal region) of human YANK2. Entrez Gene ID:...
Biology Products:
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
Breaking Biology Technology: